US5346488A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Laser-induced ablation of atherosclerotic plaque
Assignee: General Hospital Corp
•
Filing: 1992-03-02
•
Granted: 1994-09-13
•
Expires: 2012-03-02
Abstract
Abstract A method of ablating atherosclerotic plaque by means of short-duration laser light pulses. A carotenoid, such as beta-carotene, is preferably administered to the patient by injection or ingestion prior to exposing the plaque with laser light. Research data obtained by analysis of the absorption characteristics of plaque and the healthy arterial tissue reveals that the plaque may be selectively ablated without damaging the surrounding normal tissue by illuminating the plaque with laser light having a wavelength of about 430 to about 510 nanometers such that the relative absorption coefficient exhibited by the plaque is more than 1.5 times the absorption coefficient of the arterial tissue. Short duration laser light pulses preferably illuminate the plaque for less than the thermal relaxation time of the volume of exposed material. The intensity of the laser light is preferably in the range from about 1 to about 9 joules/cm2 in order to ablate the plaque without endangering the surrounding tissue. The carotenoid administered to the patient enhances the absorption coefficient of the plaque to facilitate ablation and additionally facilitates the detection of the plaque.
Inventors
- 👤 Martin Prince
- 👤 Allan Oseroff
- 👤 John A. Parrish
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 02:04
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B18/245; G; G02; G02B; G02B6/00; G02B6/24; G02B6/42; G02B6/4201; G02B6/4204; G02B6/4214; G02B6/4296; A61B17/00; A61B2017/00017; A61B2017/00137; A61B2017/00154; A61B17/22; A61B2017/22082; A61B2017/22085; A61B2017/22087; A61B2018/00636
Claims Analysis
Total Claims: 35
Claim 1
Independent Claim
56 words
A method of enhancing absorption of light by atherosclerotic plaque in a human patient to improve discrimination of said atherosclerotic plaque from surrounding tissue by light, comprising, the steps of: administering a carotenoid to said human patient whereby at least a portion of said carotenoid accumulates in said atherosclerotic plaque thereby altering said atherosclerotic plaque's composition.
Claim 2
Independent Claim
56 words
A method of enhancing absorption of light by atherosclerotic plaque in a human patient to improve discrimination of said atherosclerotic plaque from surrounding tissue by light, comprising, the steps of: administering a carotenoid to said human patient whereby at least a portion of said carotenoid accumulates in said atherosclerotic plaque thereby altering said atherosclerotic plaque's composition.
Claim 3
Dependent Claim
16 words
The method of claim 1 wherein said step of administering said carotenoid comprises administering by injection.
Claim 4
Dependent Claim
20 words
The method of claim 2 wherein said step of administering said carotenoid comprises injecting said carotenoid at least once daily.
Claim 5
Dependent Claim
31 words
The method of claim 3 wherein said said step of administering carotenoid comprises injecting said carotenoid at least once daily for at least one week prior to exposure to said light.
Claim 6
Dependent Claim
20 words
The method of claim 1 wherein said step of administering said carotenoid comprises administering said carotenoid by injection or ingestion.
Claim 7
Dependent Claim
14 words
The method of claim 5 wherein said carotenoid is administered at least once daily.
Claim 8
Dependent Claim
31 words
The method of claim 5 wherein said step of administering said carotenoid comprises administering said carotenoid at least once daily for at least one week prior to exposure to said light.
Claim 9
Independent Claim
53 words
A method of enhancing absorption of light by atherosclerotic plaque in a human patient to improve elimination of said atherosclerotic plaque by light, comprising, the steps of: administering a carotenoid to said human patient whereby at least a portion of said carotenoid accumulates in said atherosclerotic plaque thereby altering said atherosclerotic plaque's composition.
Claim 10
Independent Claim
53 words
A method of enhancing absorption of light by atherosclerotic plaque in a human patient to improve elimination of said atherosclerotic plaque by light, comprising, the steps of: administering a carotenoid to said human patient whereby at least a portion of said carotenoid accumulates in said atherosclerotic plaque thereby altering said atherosclerotic plaque's composition.
Claim 11
Dependent Claim
18 words
The method of claim 8 wherein said step of administering said carotenoid comprises administering said carotenoid by injection.
Claim 12
Dependent Claim
20 words
The method of claim 9 wherein said step of administering said carotenoid comprises injecting said carotenoid at least once daily.
Claim 13
Dependent Claim
30 words
The method of claim 10 wherein said step of administering said carotenoid is injected at least once daily for at least one week prior to the exposure to said light.
Claim 14
Dependent Claim
18 words
The method of claim 8 wherein said step of administering said carotenoid comprises administering said carotenoid by ingestion.
Claim 15
Dependent Claim
20 words
The method of claim 12 wherein said step of administering said carotenoid comprises administering said carotenoid at least once daily.
Claim 16
Dependent Claim
32 words
The method of claim 13 wherein said step of administering said carotenoid comprises administering said carotenoid at least once daily for at least one week prior to the exposure to said light.
Claim 17
Independent Claim
119 words
A method of ablating atherosclerotic plaque within a blood vessel in a human patient comprising, administering to said patient a carotenoid which is selectively taken up by said atherosclerotic plaque; and exposing said atherosclerotic plaque to pulsed laser light having: a wavelength defined by a ratio of absorption coefficients of said atherosclerotic plaque to normal human aortic endothelium being at least 1.5:1, a pulse duration defined as being less than a thermal relaxation time of the atherosclerotic plaque exposed to said pulsed laser light, and a beam intensity defined as being capable of heating said atherosclerotic plaque, at the wavelength and pulse duration employed, to effect ablation of said atherosclerotic plaque without removal of surrounding normal human aortic endothelium.
Claim 18
Independent Claim
119 words
A method of ablating atherosclerotic plaque within a blood vessel in a human patient comprising, administering to said patient a carotenoid which is selectively taken up by said atherosclerotic plaque; and exposing said atherosclerotic plaque to pulsed laser light having: a wavelength defined by a ratio of absorption coefficients of said atherosclerotic plaque to normal human aortic endothelium being at least 1.5:1, a pulse duration defined as being less than a thermal relaxation time of the atherosclerotic plaque exposed to said pulsed laser light, and a beam intensity defined as being capable of heating said atherosclerotic plaque, at the wavelength and pulse duration employed, to effect ablation of said atherosclerotic plaque without removal of surrounding normal human aortic endothelium.
Claim 19
Dependent Claim
15 words
The method of claim 15 wherein said step of administering said carotenoid comprises administering β-carotene.
Claim 20
Dependent Claim
25 words
The method of claim 16 wherein each said step of administering β-carotene comprises administering a dosage of between 100 mg and 5,000 mg per day.
Claim 21
Dependent Claim
21 words
The method of claim 17 wherein said step of administering includes administering a dosage of at least 300 mg per day.
Claim 22
Dependent Claim
15 words
The method of claim 15 wherein said step of administering includes intravenously administrating said carotenoid.
Claim 23
Dependent Claim
32 words
The method of claim 15 wherein said administering step includes carrying out said administering step and is carried out at least once daily for at least two days prior to said exposure.
Claim 24
Dependent Claim
32 words
The method of claim 20 wherein said step of administrating includes intravenously administrating said carotenoid at least once daily for at least one week prior to said exposure to said laser light.
Claim 25
Independent Claim
148 words
A method of ablating atherosclerotic plaque in a human patient, comprising, in combination, the steps of: increasing an absorption coefficient of said atherosclerotic plaque for pulsed laser light having a wavelength within a predetermined range by introducing a carotenoid into the human patient's bloodstream wherein said carotenoid preferentially accumulates in said atherosclerotic plaque; generating multiple pulses of laser light having a wavelength defined as being within said predetermined range, having a pulse duration defined as being less than a thermal relaxation time of the atherosclerotic plaque exposed to said multiple pulses of laser light, and having a pulse fluence defined as being within a range from 1 to 9 joules per square centimeter, such that said multiple pulses of laser light effects ablation of said atherosclerotic plaque as altered by the carotenoid accumulated in said atherosclerotic plaque; exposing said atherosclerotic plaque to said multiple pulses of laser light.
Claim 26
Independent Claim
148 words
A method of ablating atherosclerotic plaque in a human patient, comprising, in combination, the steps of: increasing an absorption coefficient of said atherosclerotic plaque for pulsed laser light having a wavelength within a predetermined range by introducing a carotenoid into the human patient's bloodstream wherein said carotenoid preferentially accumulates in said atherosclerotic plaque; generating multiple pulses of laser light having a wavelength defined as being within said predetermined range, having a pulse duration defined as being less than a thermal relaxation time of the atherosclerotic plaque exposed to said multiple pulses of laser light, and having a pulse fluence defined as being within a range from 1 to 9 joules per square centimeter, such that said multiple pulses of laser light effects ablation of said atherosclerotic plaque as altered by the carotenoid accumulated in said atherosclerotic plaque; exposing said atherosclerotic plaque to said multiple pulses of laser light.
Claim 27
Dependent Claim
14 words
The method of claim 22 wherein said step of administering carotenoid comprises administering beta-carotene.
Claim 28
Dependent Claim
40 words
The method of claim 22 wherein said step of generating multiple pulses of laser light comprises generating said pulse fluence of said multiple pulses of laser light to be within a range from 1 to 5 joules per square centimeter.
Claim 29
Dependent Claim
30 words
The method of claim 22 wherein said step of generating multiple pulses of laser light comprises generating said pulse duration to be less than 1/10th of the thermal relaxation time.
Claim 30
Dependent Claim
29 words
The method of claim 22 wherein said step of generating multiple pules of laser light comprises generating said pulse duration of said laser light to be about 1 microsecond.
Claim 31
Dependent Claim
32 words
The method of claim 22 wherein said step of generating multiple pules of laser light comprises generating said predetermined range of wavelengths to be within a range from 430 to 510 nanometers.
Claim 32
Dependent Claim
57 words
The method of claim 22 further comprising detecting the atherosclerotic plaque by exposing said atherosclerotic plaque to pulsed laser light having a wavelength and a pulse fluence selected to detect said atherosclerotic plaque and wherein, once detected, the atherosclerotic plaque is exposed to said pulsed laser light wherein said pulsed laser light substantially ablates said atherosclerotic plaque.
Claim 33
Dependent Claim
18 words
The method of claim 22 wherein said step of introducing said carotenoid comprises introducing by ingestion or injection.
Claim 34
Dependent Claim
28 words
The method of claim 29 wherein said carotenoid comprises introducing said carotenoid at least once a day prior to exposing said atherosclerotic plaque to said pulsed laser light.
Claim 35
Dependent Claim
14 words
The method of claim 30 wherein said step of inducing carotenoid comprises introducing beta-carotene.
References Cited (Backward Citations)
US3769963A
Cited
US4669467A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-09-12 | 1998-03-14 | 1998-09-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-09-12 | 2002-03-14 | 2002-09-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-09-12 | 2006-03-14 | 2006-09-13 | $7700.00 | Window Closed / Lapsed |